Novo Nordisk A/S (NVO)

NYSE: NVO · USD

$38.3

-0.42 (-1.1%)· Recorded snapshot

Market cap	166B
Revenue (ttm)	50.3B
Net income (ttm)	17.8B
EPS (ttm)	$3.91
Shares out	4.4B
P/E (trailing)	9.8x
P/E (forward)	11.5x
Dividend	$1.28 (3.36%)
Volume	10,499,943
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 50.3B
Net income (ttm): 17.8B
EPS (ttm): $3.91
P/E (trailing): 9.8x
P/E (forward): 11.5x
Market cap: 166B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E9.8

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NVO indicators

Market & fundamental data

Available fields

286

Groups with data

Currency

DKK

Showing 286 of 286 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000353278
Company name	Novo Nordisk A/S
Country	Denmark
Country code	US
CUSIP number	670100205
Earnings date	2026-11-04
Earnings time	bmo
Employees	66,700
Employees change	-11,687
Employees growth	-14.91%
Enterprise value	$180.2B
Exchange	NYSE
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
Is SPAC	No
ISIN number	US6701002056
Last 10-K release date	2026-02-04
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2023-09-20
Last stock split type	Forward
Market cap	$166B
Market cap category	Large-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$38.25
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	NVO
Tags	weight-loss
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	10.95x
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	10.23%
EV/Earnings	10.25x
EV/EBIT	7.4x
EV/EBITDA	6.87x
EV/FCF	16.14x
EV/Sales	3.62x
FCF / EV yield	6.2%
FCF yield	6.72%
Forward EV/Sales	4.03x
Forward P/E	11.49x
Forward P/S	3.72x
Graham number	26.3424
Graham upside	-30.83%
Industry forward P/E	18.51x
Industry P/E	35.9x
Lynch fair value	$85.76
Lynch upside	125.19%
P/(FCF - SBC) ratio	15.17x
P/(OCF - SBC) ratio	8.65x
P/B ratio	4.97x
P/E ratio	9.78x
P/FCF ratio	14.88x
P/OCF ratio	8.56x
P/S ratio	3.34x
Price / tangible book value	11.09x
Price/EBITDA ratio	6.34x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	23.02%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	$266,774
Profitable quarters	78
Profitable years	26
Revenue per employee	$754,734
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	25
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	25
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-8.4B
Depreciation and amortization	$1.8B
EBIT	$24.7B
EBITDA	$26.5B
EPS	$3.91
FCF per share	$2.55
Financing cash flow	$-3.4B
Free cash flow	$11.3B
Free cash flow minus SBC	$11.1B
Gross profit	$41.3B
Income taxes	$4.9B
Investing cash flow	$-12.8B
Net borrowing	$5.4B
Net cash flow	$4B
Net income	$17.8B
Operating cash flow minus SBC	$19.4B
Operating income	$24.7B
Revenue	$50.3B
Stock-based compensation	$219.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	$7.64
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.89
Goodwill	$3B
Interest coverage	1,566.84
Long-term assets	$59.8B
Long-term liabilities	$21.5B
Net cash (debt)	$-14.5B
Net cash / market cap	-8.64%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.29
Piotroski F-Score	5
Property, plant and equipment	$34.5B
Shareholders' equity	$33.8B
Tangible book value	$15.2B
Tangible book value per share	$3.42
Total assets	$90.9B
Total cash	$6.9B
Total debt	$21.4B
Total liabilities	$57.1B
WACC	5.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	$31.1B
Current liabilities	$35.6B
Current ratio	0.87
Inventory turnover	1.22
Net working capital	$-8.7B
Quick ratio	0.64
Working capital	$-4.6B
Working capital turnover	-1.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	4.13%
Dividend growth (10Y)	9.54%
Dividend growth (3Y)	20.32%
Dividend growth (5Y)	19.54%
Dividend growth years	6
Dividend payment date	2026-08-25
Dividend payment years	26
Dividend payout frequency	Semi-Annual
Dividend per share	$1.28
Dividend yield	3.36%
Ex-dividend date	2026-08-17
FCF payout ratio	50.26%
Last dividend	$0.41
Payout ratio	32.83%
Shareholder yield	3.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	86.49%
10Y return CAGR	8.22%
10Y total return	120.36%
150-day SMA	$43.52
15Y price change	246.92%
15Y return CAGR	10.38%
15Y total return	339.88%
1D price change	-1.09%
1M price change	-1.61%
1M total return	-1.61%
1W price change	-2.99%
1W total return	-2.99%
1Y price change	-27.82%
1Y return CAGR	-25.38%
1Y total return	-25.37%
20-day SMA	$38.45
200-day SMA	$44.39
20Y price change	921.82%
20Y return CAGR	14.03%
20Y total return	1,282.16%
3M price change	-23.14%
3M total return	-22.45%
3Y price change	-59.17%
3Y return CAGR	-24.29%
3Y total return	-56.6%
50-day SMA	$41.50
50-day SMA vs 200-day SMA	50under200
52-week high	$64.16
52-week high date	2026-01-23
52-week low	$35.12
52-week low date	2026-03-30
5Y price change	-27.75%
5Y return CAGR	-4.77%
5Y total return	-21.69%
6M price change	-7.34%
6M total return	-6.51%
All-time high	$148.15
All-time high date	2024-06-25
All-time low	$0.09
All-time low date	1987-10-20
Average true range (ATR)	$0.81
Average volume	9.8M
Beta (5Y)	0.38
Change from 52-week high	-40.38%
Change from 52-week low	8.91%
Change from all-time high	-74.23%
Change from all-time low	44,186.54%
Change from open	0.53%
Day's gap	-1.6%
Dollar volume	$401.6M
High price	$38.54
Low price	$37.97
Monthly RSI	35.39
Open price	$38.05
Position in 52-week range	49.12%
Premarket change	-1.34%
Premarket close	$38.67
Premarket price	$38.15
Premarket volume	318.7K
Previous close	$38.67
Price vs 150-day SMA	-12.28%
Price vs 20-day SMA	-0.71%
Price vs 200-day SMA	-14%
Price vs 50-day SMA	-8.01%
Relative volume	1.07
RSI	39.99
Sharpe ratio	-0.5
Sharpe ratio (3Y)	-0.55
Sharpe ratio (5Y)	-0.02
Sortino ratio	-0.55
Sortino ratio (3Y)	-0.59
Sortino ratio (5Y)	0.11
Volume	10.5M
Weekly RSI	37.05
YTD price change	-24.97%
YTD total return	-22.42%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Float percentage	71.57%
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.52%
Shares outstanding	4.4B
Short % of shares	1%
Short ratio	2.3 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	498

Deeper analysis on NVO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NVO report

Is a complete NVO research report available?

No complete published report is available for Novo Nordisk A/S (NVO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Novo Nordisk A/S (NVO)

Price

Financial snapshot

Fair-value bridge

Latest news · NVO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NVO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NVO

Frequently asked questions